They focused on Forkhead box M1 (FOXM1), which is linked to tumor cell cycle, drug resistance, and tumor immune escape, and reported that FOXM1 affected PD‐L1 levels through the Notch pathway, thereby promoting gastric cancer (GC) progression. Here, FOXM1 is linked to gastric cancer.